Form EFFECT Galmed Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 2, 2025 |
| Accession Number: | 0001493152-25-012440 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Galmed develops dissolving film form of Aramchol for Parkinson's disease
- Bitdeer Announces Second Quarter 2026 Earnings Conference Call for August 10th 2026
- Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
